Back to Trades
Inhibikase Therapeutics, Inc.
IKTCIK: 0001750149
Follow IKT
Track Inhibikase Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.
Inhibikase Therapeutics, Inc. (IKT) has recorded 10 insider filings from 6 unique insiders, totaling $16.8M in trading activity (net buying). Insiders have purchased $3.0M and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Iwicki Mark T. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$16.8M
Purchases
$3.0M
Sales
$0
Unique Insiders
6
Recent Insider Trades
10 loaded
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Other | $0 |
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Aurentz Vincent | Insider | Other | $0 |
| Feb 24 | IKT Inhibikase Therapeutics, Inc. | Munshi Amit | Insider | Other | $0 |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | Iwicki Mark T | Insider | Other | $0 |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Other | $0 |
| Jan 7 | IKT Inhibikase Therapeutics, Inc. | McIntyre David | Insider | Other | $0 |
| Nov 24 | IKT Inhibikase Therapeutics, Inc. | Sands Capital Life Sciences Pulse Fund II, L.P. | 10% Owner | Buy | $3.0M |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Aurentz Vincent | Insider | Other | $0 |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Cabell Christopher | Insider | Other | $0 |
| Aug 28 | IKT Inhibikase Therapeutics, Inc. | Munshi Amit | Insider | Grant | $0 |
10 filings